Patent family “Isolation of Stem/Progenitor Cells from Amniotic Membrane of Umbilical Cord” 

 

Granted

U.S.A Patent 

Taiwan Patent 

Malaysia Patent 

Europe (17 Territories) Patent 

United Kingdom Patent 

Singapore Patent 

Australia Patent 

China Patent 

India Patent 

Indonesia Patent 

Israel Patent 

Japan Patent 

Japan Patent 

Korea Patent 

Mexico Patent 

New Zealand Patent 

Russia Patent 

South Africa Patent 

Vietnam Patent 

Hong Kong Patent 

 

 

Patent family “Isolation and Cultivation of Stem/Progenitor Cells from the Amniotic Membrane of Umbilical Cord and uses of Cells Differentiated Therefrom”

 

Granted

U.S.A. Patent 

U.S.A. Patent 

Europe Patent

China Patent 

Make an informed choice. Select a cord banking service that is licensed to offer complete coverage for all stem cell therapies derived from your stored cord. 

Umbilical cord lining tissue banked by non-licensed cord blood banks may not provide the stem cell yield or quality that CellResearch Corporation’s proprietary and patented protocols can provide — this may affect its suitability for future therapeutic use. In addition, these blood banks and medical institutions that offer CellResearch Corporation's patented protocols — which include ALL cord lining stem cell therapies — are at risk of patent infringement. 

GlobalCord is operated bv CellResearch Corporation and its partners. Cords banked through GlobalCord are covered by CellResearch Corporation’s patent licensure